For Eye Care Professionals

Are your patients experiencing the symptoms of digital device overuse?

In the past decade, a dramatic shift has occurred in how society visualizes the world.

People now spend a majority of their day immersed in visual activity on digital devices. As a result, the increased demand on our eyes is relentless.

What Eye Care Professionals Are Saying

What Eye Care Professionals Are Saying

Trigeminal Nerve Over-Stimulation:

  • Neck, shoulder, back pain
  • Eye strain
  • Headache
  • Blurred vision
  • Dry eyes

Introducing a new breakthrough technology: neurolens® System


SightSync® uses proprietary testing techniques and sophisticated eye tracking technology to objectively measure the amount of binocular misalignment a patient is experiencing at distance and near.

SightSync® creates a dynamic customized measurement of misalignment at 6 meters and 50 cm, analyzing all elements of ocular fusion, including:

  • Heterophoria
  • Vergence conditioning
  • Binocular peripheral fusion
  • Fixation disparity
  • Accomodative convergence response
  • Alternating monocular central fixation

How Is It Different from Traditional Testing?

  • Objective: 100% objective. No patient or operator interaction. Sophisticated eye-tracking.
  • Accurate: Measurements are calculated to the one-hundredth of a prism diopter.
  • Efficient: Testing performed in less than three minutes by a technician.
  • Standardization: Consistent, reproducible measurement (standard deviation is <0.8 prism diopter).

Patented Progressive Prism Lens Design

A proprietary lens technology integrating a progressive prism design in conjunction with the patient’s refractive prescription. Progressive prism technology enables practitioners to relieve binocular misalignment detected at distance, intermediate, and near in a single lens. Research indicates that over 90% of patients experience a larger misalignment when fusing at near than at distance. This progressive prism lens design may be offered as a single vision or progressive addition lens.

Clinical Results

Digital Vision Syndrome (DVS) Study

Patient Reported Symptom Relief – 90 Day

  • 22 participants – inclusion criteria = Qualified as DVS sufferer by validated questionnaire
  • 100% positive response to treatment at 90 days
  • 86% reported DVS symptoms as “Reduced Substantially” or “Basically Gone”

Chronic Daily Headache Study

Patient Reported Symptom Relief – 90 Day

  • 179 participants – inclusion criteria = refractory, end-of-line chronic headache & migraine
  • 81.6% positive response to treatment at 90 days
  • 54% reported headache symptoms as “Reduced Substantially” or “Basically Gone”

Proven Relief

* 2016 data, 12 practices, 1300 paying patients surveyed, 360 responses to commercial survey ~28% response rate.

Contact Us